Related Experiment Videos
Vinblastine-dependent down-modulation of TNF receptors in human osteosarcoma cells is mediated by protein kinase C
D Boscoboinik1, T Galeotti, A Azzi
1Institut für Biochemie und Molekularbiologie, Universität Bern, Switzerland.
Abstract:
The binding of tumor necrosis factor (TNF) to a human osteogenic sarcoma cell line (Saos-2) was investigated. These cells express two types of receptors as determined by specific monoclonal antibodies. Vinblastine induced a down-modulation of these receptors weaker than the one produced by phorbol esters or okadaic acid treatment. On exposure of cells to 10 microM vinblastine for two hours an approximately 55-65% diminution of TNF binding was observed, but only 20% reduction occurred under long-term vinblastine treatment. TNF receptor down-modulation induced by vinblastine was partially prevented by protein kinase C inhibitors or protein kinase C depletion. It is suggested that the regulation of TNF binding to each one of its receptors in Saos-2 cells always occurs in a phosphorylation-dependent manner.
Insights
Vinblastine treatment reduces tumor necrosis factor (TNF) binding to Saos-2 cells, indicating receptor modulation. This process involves phosphorylation, suggesting a key regulatory mechanism for TNF receptor interactions.
Area of Science:
- Oncology
- Cell Biology
- Immunology
Background:
- Tumor necrosis factor (TNF) is a key cytokine involved in inflammation and immune responses.
- Saos-2 cells, a human osteogenic sarcoma line, express TNF receptors.
- Understanding TNF receptor regulation is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the effect of vinblastine on TNF binding to Saos-2 cells.
- To elucidate the role of phosphorylation in TNF receptor regulation by vinblastine.
- To compare vinblastine's effect with other known receptor modulators.
Main Methods:
- Utilized Saos-2 cell line for experiments.
- Employed monoclonal antibodies to identify TNF receptor types.
- Administered vinblastine, phorbol esters, and okadaic acid to assess receptor modulation.
- Investigated the role of protein kinase C (PKC) inhibitors and depletion.
Main Results:
- Vinblastine treatment caused a significant (55-65%) but transient diminution of TNF binding.
- Long-term vinblastine exposure resulted in a lesser reduction (20%) in TNF binding.
- PKC inhibitors or depletion partially prevented vinblastine-induced TNF receptor down-modulation.
- These findings suggest a phosphorylation-dependent regulation of TNF receptor binding.
Conclusions:
- Vinblastine modulates TNF receptor binding in Saos-2 cells, with a time-dependent effect.
- Phosphorylation, potentially mediated by PKC, plays a critical role in regulating TNF receptor interactions.
- The study highlights the complex phosphorylation-dependent mechanisms governing TNF receptor function in osteogenic sarcoma cells.